Are Your Machine Identities Truly Secure? The notion of securing Non-Human Identities (NHIs) often takes center stage. Where machine identities become more prevalent across industries, managing these ...

The rules of the hardware market are being rewritten, and companies that once thrived on unit sales are realizing that services drive long-term profitability. For an embedded software development ...

The rise in popularity for JDM culture has a lot to do with the Japanese car manufacturers themselves, many of whom were on ...

A new partnership, with funding from Innovate UK, aims to investigate the possibility of using continuous manufacturing processes in gene therapy. Few people doubt the potential for gene therapies to ...

Discover Ajinomoto’s growth strategy in Latin America, focusing on food innovation, sustainability, and market expansion ahead of COP30.

NCLT Ahmedabad held that statutory demand notice duly signed by Operational Creditor and served upon Corporate Debtor through advocate is valid in eye of law. Accordingly, Corporate Debtor [Vimla ...

The longest-running, bestselling EVs in their class benefit from incremental improvements, but one benefits more.

In January 2024, LEQEMBI was approved for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively referred to as ...

LEQEMBI IQLIK, approved by the U.S. FDA in August 2025, is the first and only anti-amyloid treatment to offer an at-home injection after initial treatment of 18 months ...

Speaking at their global innovation conference 2025 in Wuhu China, Chery's Executive Vice President, Gao Xinhua, laid out a ...